ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  You, Dong Gil ^a,b   Deepagan, V G ^a   Um, Wooram ^a,b   Jeon, Sangmin ^a,b   Son, Sejin ^b   Chang, Hyeyoun ^b,c   Yoon, Hwa In ^b,d   Cho, Yong Woo ^d   Swierczewska, Maggie ^e   Lee, Seulki ^e   Pomper, Martin G ^e   Kwon, Ick Chan ^b   Kim, Kwangmeyung ^b,c   Park, Jae Hyung ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Hanyang University   (South Korea)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TITANIUM; TITANIUM DIOXIDE;

ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; DRUG SCREENING; LIVER NEOPLASMS, EXPERIMENTAL; METABOLIC ACTIVATION; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NIH 3T3 CELL LINE; RADIATION RESPONSE; TISSUE DISTRIBUTION; TUMOR CELL LINE; ULTRASOUND;

ACTIVATION, METABOLIC; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; REACTIVE OXYGEN SPECIES; TISSUE DISTRIBUTION; TITANIUM; ULTRASONIC WAVES;

EID: 84961825380     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23200     Document Type: Article

References (38)

1. Martin, J. et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann. Thorac. Surg. 72, 1149-1154 (2001).
2. Nowak, A. K., Robinson, B. W. S., Lake, R. A. Gemcitabine Exerts a Selective Effect on the Humoral Immune Response: Implications for Combination Chemo-immunotherapy. Cancer Res. 62, 2353-2358 (2002).
3. Dolmans, D. E. J. G. J., Fukumura, D., Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387 (2003).
4. Moan, J., Berg, K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549-553 (1991).
5. Gollnick, S. O. et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88, 1772-1779 (0000).
6. Firczuk, M., Nowis, D., Golab, J. PDT-induced inflammatory and host responses. Photochem. Photobiol. Sci. 10, 653-663 (2011).
7. Cheon, Y. K. et al. Diagnostic Utility of Interleukin-6 (IL-6) for Primary Bile Duct Cancer and Changes in Serum IL-6 Levels Following Photodynamic Therapy. Am. J. Gastroenterol 102, 2164-2170 (2007).
8. Wilson, B. Photodynamic therapy for cancer: Principles. Can. J. Gastroenterol. 16, 393-396 (2002).
9. Hong, G. et al. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat. Med. 18, 1841-1846 (2012).
10. Goss, S. A., Frizzell, L. A., Dunn, F. Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med. Biol. 5, 181-186 (1979).
11. Mitragotri, S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug. Discov. 4, 255-260 (2005).
12. Hallez, L. et al. Characterization of HIFU transducers designed for sonochemistry application: Cavitation distribution and quantification. Ultrasonics 50, 310-317 (2010).
13. Cao, H., Yin, H., Qiao, Y., Zhang, S., Wan, M. Sonochemiluminescence observation and acoustic detection of cavitation induced by pulsed HIFU at a tissue-fluid interface. Ultrason. Sonochem. 20, 1370-1375 (2013).
14. Kuroki, M. et al. Sonodynamic Therapy of Cancer Using Novel Sonosensitizers. Anticancer Res. 27, 3673-3677 (2007).
15. Hu, Z. et al. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis. J. Dermatol. Sci. 79, 155-162 (2015).
16. Fisichella, M. et al. Reply to comment on Fisichella et al. (2012), "Intestinal toxicity evaluation of TiO2 degraded surface-treated nanoparticles: a combined physico-chemical and toxicogenomics approach in Caco-2 cells" by Faust et al. Part. Fibre Toxicol. 9, 39 (2012).
17. Fabian, E. et al. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 82, 151-157 (2008).
18. Qin, Y. et al. Highly water-dispersible TiO2 nanoparticles for doxorubicin delivery: effect of loading mode on therapeutic efficacy. J. Mater. Chem. 21, 18003-18010 (2011).
19. Paunesku, T. et al. Biology of TiO2-oligonucleotide nanocomposites. Nat. Mater. 2, 343-346 (2003).
20. Hou, Z. et al. UV-Emitting Upconversion-Based TiO2 Photosensitizing Nanoplatform: Near-Infrared Light Mediated in Vivo Photodynamic Therapy via Mitochondria-Involved Apoptosis Pathway. ACS Nano 9, 2584-2599 (2015).
21. Yamaguchi, S. et al. Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: Comparison of cytotoxic mechanism with photodynamic therapy. Ultrason. Sonochem. 18, 1197-1204 (2011).
22. Sugahara, S., Kajiki, M., Kuriyama, H., Kobayashi, T. Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992). J. Control. Release 117, 40-50 (2007).
23. Chang, R. L. S., Crawford, M. P., West, M. D. An assessment of the potential use of anionic dextrans as a plasma substitute. J Biomed Eng. 2, 41-44 (1980).
24. Thambi, T. et al. Bioreducible Carboxymethyl Dextran Nanoparticles for Tumor-Targeted Drug Delivery. Adv. Healthc. Mater. 3, 1829-1838 (2014).
25. Thambi, T. et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 35, 1735-1743 (2014).
26. Yoon, H. Y. et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 33, 3980-3989 (2012).
27. Yoon, I., Li, J. Z., Shim, Y. K. Advance in Photosensitizers and Light Delivery for Photodynamic Therapy. Clin. Endosc. 46, 7-23 (2013).
28. Illing, R. O. et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br. J. Cancer 93, 890-895 (2005).
29. Tsuru, H., Shibaguchi, H., Kuroki, M., Yamashita, Y., Kuroki, M. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer. Free Radic. Biol. Med. 53, 464-472 (2012).
30. Borsig, L. et al. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. 98, 3352-3357 (2001).
31. Volanti, C. et al. Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23, 8649-8658 (2004).
32. Van, D. et al. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207, 105-113 (2003).
33. Paparel, P. et al. Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma. BJUI. 95, 881-885 (2005).
34. Gelet, A. et al. Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome. Eur. Urol. 40, 124-129 (2001).
35. Prat, F. et al. In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. Br. J. Cancer 68, 13-17 (1993).
36. Curiel, L., Paparel, P., Chesnais, S., Gelet, A., Chapelon, J. Y. HIFU and Chemotherapy Synergistic Inhibitory Effect on Dunning AT2 Tumour?Bearing Rats. AIP. Conference Proceedings 754, 191-195 (2005).
37. Tang, W., Xu, H., Kopelman, R., Philbert, M. A., Photodynamic Characterization and In Vitro Application of Methylene Bluecontaining Nanoparticle Platforms. Photochem. Photobiol. 81, 242-249 (2005).
38. Bourre, L. et al. Indirect detection of photosensitizer ex vivo. J. Photochem. Photobiol. B 67, 23-31 (2002).